logo

PPAR Research

PPAR Research / Table of Contents

Table of Contents

Table of Contents

  • PPAR Research -
  • Special Issue
  • Volume 2008
  • - Article ID 651419
  • - Research Article

Activation of Penile Proadipogenic Peroxisome Proliferator-Activated Receptor with an Estrogen: Interaction with Estrogen Receptor Alpha during Postnatal Development

Mahmoud M. Mansour | Hari O. Goyal | ... | Edward E. Morrison
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 250568
  • - Review Article

Chondrosarcoma and Peroxisome Proliferator-Activated Receptor

K. Nishida | T. Kunisada | ... | T. Ozaki
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 906542
  • - Review Article

PPAR Ligands as Antitumorigenic and Antiangiogenic Agents

Ambra Pozzi | Jorge H. Capdevila
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 204514
  • - Review Article

Peroxisome Proliferator-Activated Receptors (PPARs) as Potential Inducers of Antineoplastic Effects in CNS Tumors

Lars Tatenhorst | Eric Hahnen | Michael T. Heneka
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 254108
  • - Review Article

Activated PPAR Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells

Shou Wei Han | Jesse Roman
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 638356
  • - Editorial

PPARs in Neuroinflammation

Michael K. Racke | Paul D. Drew
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 904041
  • - Research Article

Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling

Giulia Cantini | Adriana Lombardi | ... | Michaela Luconi
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 658520
  • - Review Article

PPAR Regulation of Inflammatory Signaling in CNS Diseases

John J. Bright | Saravanan Kanakasabai | ... | Sharmistha Chakraborty
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 542694
  • - Review Article

PPAR and Proline Oxidase in Cancer

James M. Phang | Jui Pandhare | ... | Yongmin Liu
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 352437
  • - Review Article

Role of Peroxisome Proliferator-Activated Receptor Alpha in the Control of Cyclooxygenase 2 and Vascular Endothelial Growth Factor: Involvement in Tumor Growth

Raquel Grau | Manuel D. Díaz-Muñoz | ... | Miguel A. Iñiguez
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 230893
  • - Review Article

PPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes

Ancha Baranova
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 256251
  • - Review Article

Mitochondria, PPARs, and Cancer: Is Receptor-Independent Action of PPAR Agonists a Key?

Roberto Scatena | Patrizia Bottoni | Bruno Giardina
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 403896
  • - Review Article

PPARs in Alzheimer's Disease

Markus P. Kummer | Michael T. Heneka
  • PPAR Research -
  • Special Issue
  • - Volume 2008
  • - Article ID 546753
  • - Review Article

PPAR Alpha Regulation of the Immune Response and Autoimmune Encephalomyelitis

Yuhong Yang | Anne R. Gocke | ... | Michael K. Racke
  • PPAR Research -
  • Special Issue
  • Volume 2008
  • - Article ID 524671
  • - Review Article

The Role of PPAR Ligands in Controlling Growth-Related Gene Expression and their Interaction with Lipoperoxidation Products

Giuseppina Barrera | Cristina Toaldo | ... | Carlo Ferretti
PPAR Research
Journal metrics
See full report
Acceptance rate11%
Submission to final decision75 days
Acceptance to publication21 days
CiteScore5.800
Journal Citation Indicator0.720
Impact Factor2.9
See full report
APC$1550
Submit Evaluate your manuscript with the free Manuscript Language Checker
Author guidelines Editorial board Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.